Description
The aim of this subject is to apply and further advance knowledge and critical thinking skills that students have developed throughout their degree program. Students will be required to think across disciplines (including anatomy, physiology, cell biology, genetics, biochemistry, pharmacology, pathology, immunology and microbiology) in their quest to understand each disease mechanism. This subject applies problem-based learning (PBL) as its central tenet to promote active and self-directed learning.
Subject details
Type | Undergraduate |
Code | BMED13-125 |
EFTSL | 0.125 |
Faculty | Faculty of Health Sciences & Medicine |
Semesters offered |
|
Credit | 10 |
Study abroad | Available to Study Abroad students |
Study areas |
|
Subject fees |
|
Learning outcomes
1. Demonstrate knowledge and understanding of mechanisms of disease and the body's response at the systemic, cellular and molecular level
2. Demonstrate knowledge and understanding of the clinical manifestations, diagnostic procedures and methods of treatment/management of common human diseases
3. Access and interpret biomedical information from journals, electronic databases, websites and other sources
4. Critically evaluate new knowledge with an understanding of the basic concepts and principles of scientific investigation in biomedical sciences
5. Demonstrate competency in effective problem-solving and critical thinking skills
Prerequisites
BMED12-120 - Pathophysiology and Pharmacology
Subject outlines
Subject dates
Standard | |
---|---|
Enrolment opens | 16/07/2017 |
Semester start | 11/09/2017 |
Subject start | 11/09/2017 |
Cancellation 1? | 25/09/2017 |
Cancellation 2? | 02/10/2017 |
Last enrolment | 24/09/2017 |
Last withdrawal? | 06/10/2017 |
Teaching census? | 06/10/2017 |
Standard Offering | |
---|---|
Enrolment opens | 12/11/2017 |
Semester start | 15/01/2018 |
Subject start | 15/01/2018 |
Cancellation 1? | 29/01/2018 |
Cancellation 2? | 05/02/2018 |
Last enrolment | 28/01/2018 |
Last withdrawal? | 09/02/2018 |
Teaching census? | 09/02/2018 |